Structure-function of α1-adrenergic receptors

被引:38
|
作者
Perez, Dianne M. [1 ]
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA
关键词
adrenergic; receptor; structure; function; modeling; mutagenesis; alpha; ligands; drug design; agonism; antagonism;
D O I
10.1016/j.bcp.2006.09.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Easson-Stedman hypothesis provided the rationale for the first studies of drug design for the alpha(1)-adrenergic receptor. Through chemical modifications of the catecholamine core structure, the need was established for a protonated amine, a beta-hydroxyl on a chiral center, and an aromatic ring with substitutions capable of hydrogen bonding. After the receptors were cloned and three alpha(1)-adrenergic receptor subtypes were discovered, drug design became focused on the analysis of receptor structure and new interactions were uncovered. It became clear that alpha(1)- and beta-adrenergic receptors did not share stringent homology in the ligand-binding pocket but this difference has allowed for more selective drug design. Novel discoveries on allosterism and agonist trafficking may be used in the future design of therapeutics with fewer side effects. This review will explore past and current knowledge of the structure-function of the alpha(1)-adrenergic receptor subtypes. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1051 / 1062
页数:12
相关论文
共 50 条
  • [1] THE ADRENERGIC-RECEPTORS - STRUCTURE-FUNCTION AND REGULATION
    LEFKOWITZ, RJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (01) : 53 - 53
  • [2] Inverse agonism at β1-adrenergic receptors
    Lohse, MJ
    Hoffmann, C
    Engelhardt, S
    INVERSE AGONISM, 2003, 1249 : 55 - 61
  • [3] α1-Adrenergic Receptors Regulate Neurogenesis and Gliogenesis
    Gupta, Manveen K.
    Papay, Robert S.
    Jurgens, Chris W. D.
    Gaivin, Robert J.
    Shi, Ting
    Doze, Van A.
    Perez, Dianne M.
    MOLECULAR PHARMACOLOGY, 2009, 76 (02) : 314 - 326
  • [4] Heterodimerization of α2A- and β1-adrenergic receptors
    Xu, JG
    He, JQ
    Castleberry, AM
    Balasubramanian, S
    Lau, AG
    Hall, RA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) : 10770 - 10777
  • [5] α1-adrenergic receptors:: New insights and directions
    Piascik, MT
    Perez, DM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (02): : 403 - 410
  • [6] Arylpiperazines with affinity toward α1-adrenergic receptors
    Manetti, F
    Corelli, F
    Strappaghetti, G
    Botta, M
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (13) : 1303 - 1321
  • [7] Structure-function relationships of the α1b-adrenergic receptor
    Scheer, A
    Fanelli, F
    Diviani, D
    de Benedetti, PG
    Cotecchia, S
    EUROPEAN UROLOGY, 1999, 36 : 11 - 16
  • [8] Autoantibodies against 1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function
    Michelucci, Antonio
    D'Elios, Mario Milco
    Sticchi, Elena
    Pieragnoli, Paolo
    Ricciardi, Giuseppe
    Fatini, Cinzia
    Benagiano, Marisa
    Niccolai, Elena
    Grassi, Alessia
    Attana, Paola
    Nesti, Martina
    Grifoni, Gino
    Padeletti, Luigi
    Abbate, Rosanna
    Prisco, Domenico
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2016, 39 (01): : 65 - 72
  • [9] Aryloxypropanolamine and catecholamine ligand interactions with the β1-adrenergic receptor:: Evidence for interaction with distinct conformations of β1-adrenergic receptors
    Konkar, AA
    Zhu, ZX
    Granneman, JG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 294 (03): : 923 - 932
  • [10] Effect of α1-adrenergic receptors in cardiac patho'hysiology
    Shannon, Richard
    Chaudhry, Mohammad
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 842 - 850